Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Schmidt, Marcus; Edlund, Karolina; Hengstler, Jan G. et al.
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast CancerCANCERS. Bd. 13. H. 14. 2021
Klein, Eva-Maria; Tichy, Diana; Salwender, Hans J. et al.
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 TrialCANCERS. Bd. 13. H. 19. 2021
Hempler, Isabelle; Riccetti, Nicola; Hermes-Moll, Kerstin et al.
Psycho-Oncological Care for People with a Migration Background and their Relatives - Results of Semi-Structured Interviews with PhysiciansPSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE. Bd. 71. H. 08. 2021 S. 335-342
Singer, Susanne; Rockenbach, Annette; Kojima, Erika et al.
Psycho-oncological care in private practices: a survey among psychotherapists with and without licence for reimbursement with public health insuranceZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE. Bd. 67. H. 2. 2021 S. 132-152
Al-Batran, Salah-Eddin; Hofheinz, Ralf-Dieter; Reichart, Alexander et al.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registryINTERNATIONAL JOURNAL OF CANCER. Bd. 148. H. 6. 2021 S. 1478-1488
Kudo, Masatoshi; Finn, Richard S.; Morimoto, Manabu et al.
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)LIVER CANCER. Bd. 10. H. 5. 2021 S. 451-460
Harter, P.; Sehouli, J.; Vergote, I et al.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian CancerNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 23. 2021 S. 2123-2131
Hippert, Felicitas; Desing, Lena; Diez, Sonja et al.
Rare Tumors in Children and Adolescents - the STEP Working Group & apos;s Evolution to a Prospective RegistryKLINISCHE PADIATRIE. Bd. 234. H. 03. 2021 S. 146-153
Heilig, C. E.; Horak, P.; Kreutzfeldt, S. et al.
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialESMO OPEN. Bd. 6. H. 6. 2021
Wockel, Achim; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 81. H. 4. 2021